Focus:
What solutions are available for producing increasingly powerful active pharmaceutical ingredients? Sarah Blackman talks to Stuart Needleman of Aptuit about the manufacturing methods used to create quality materials in a...
Can a new cholesterol polypill open the door to a global mass preventative for cardiovascular diseases? Elisabeth Fischer speaks to Gilbert Thompson, emeritus professor of clinical lipidology at Imperial College,...
Combating counterfeits: How the industry can protect products, the supply chain and patients from the black market trade.
Prostate cancer is the most common form of the disease in men but as yet, no one-size fits all treatment is available. Using detailed GlobalData research this market snapshot analyses...
Imaging biomarkers could hold the key to faster, more cost-effective drug development if used properly. Chris Lo speaks to Clinical Trials Network chairman Dr Michael Graham to find out more...
Better medicine: From needle-free to nanotechnology, new drug delivery systems are set to revolutionise medical treatment.
The paediatric drugs market is growing rapidly but is a lack of guidance putting children at risk? Elisabeth Fischer sheds some light on the restrictions surrounding paediatric drug development, the...
Effective treatments for Parkinson's disease are few and far between, but new research into novel therapies hold promise. A growing patient pool, forecasted to triple in the next 50 years,...
Virus-like particles represent one of the most exciting new technologies to rapidly produce vaccines. Elisabeth Fischer speaks to industry experts to find out about this cheaper and quicker way to...
The road to market: How pharma companies can meet the challenges of today's increasingly complex supply chains.
